首页> 外国专利> COMPOSITION FOR SUPPRESSING AUTOPHAGY IN CELLS AND PHARMACEUTICAL COMPOSITION COMPRISING SAME FOR PREVENTING OR TREATING NEOPLASTIC DISEASES OR SUPPRESSING ANTICANCER DRUG RESISTANCE

COMPOSITION FOR SUPPRESSING AUTOPHAGY IN CELLS AND PHARMACEUTICAL COMPOSITION COMPRISING SAME FOR PREVENTING OR TREATING NEOPLASTIC DISEASES OR SUPPRESSING ANTICANCER DRUG RESISTANCE

机译:抑制细胞自噬的药物组合物和组成相同的药物组合物,用于预防或治疗赘生性疾病或抑制抗癌药耐药性

摘要

The present invention relates to a polypeptide having inhibitory activity on autophagy in cells, and a composition comprising the same as an effective component for suppressing autophagy in cells, particularly tumor cells, and more specifically, to a composition for inhibiting autophagy in cells, comprising, as an effective component, a polypeptide inhibiting the mechanism regulating autophagy; and a pharmaceutical composition comprising the same for preventing or treating neoplastic diseases, or suppressing anticancer drug resistance. According to the present invention, the polypeptide according to the present invention regulates the expression of autophagy-associated proteins, p-AMPK, ATG5-ATG12, Beclin1, p-Beclin1, LC3-I, LC3-II, p-mTOR, and p62, thereby inhibiting autophagy, and thus is effective for preventing or treating neoplastic diseases, and can also suppress anticancer drug resistance.
机译:本发明涉及对细胞中的自噬具有抑制活性的多肽,以及包含其作为抑制细胞特别是肿瘤细胞中的自噬的有效成分的组合物,更具体地,涉及用于抑制细胞中的自噬的组合物,包括:作为有效成分的多肽,其抑制自噬的调节机制。药物组合物,其包含用于预防或治疗赘生性疾病或抑制抗癌药耐药性的药物组合物。根据本发明,根据本发明的多肽调节自噬相关蛋白,p-AMPK,ATG5-ATG12,Beclin1,p-Beclin1,LC3-I,LC3-II,p-mTOR和p62的表达。 ,从而抑制自噬,因此对于预防或治疗肿瘤疾病是有效的,并且还可以抑制抗癌药耐药性。

著录项

  • 公开/公告号WO2019208868A1

    专利类型

  • 公开/公告日2019-10-31

    原文格式PDF

  • 申请/专利权人 L-BASE CO.LTD.;

    申请/专利号WO2018KR06023

  • 发明设计人 JEON DO YONG;MOON CHANG HOON;JUNG JI EUN;

    申请日2018-05-28

  • 分类号C07K7/06;A61P35;A61K38;

  • 国家 WO

  • 入库时间 2022-08-21 11:52:37

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号